Global Information
회사소개 | 문의 | 비교리스트

세계의 자기주사기 시장

Autoinjectors: Global Markets

리서치사 BCC Research
발행일 2021년 11월 상품 코드 1036286
페이지 정보 영문 123 Pages
가격
US $ 5,500 ₩ 6,638,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,600 ₩ 7,966,000 PDF (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,920 ₩ 9,559,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,504 ₩ 11,471,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 자기주사기 시장 Autoinjectors: Global Markets
발행일 : 2021년 11월 페이지 정보 : 영문 123 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 자기주사기 시장 규모는 2021년에 415억 달러에 달했습니다.

이 시장은 2021-2026년 15.5%의 CAGR로 확대하며, 2026년에는 852억 달러에 달할 것으로 예측되고 있습니다.

세계의 자기주사기 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 투여 경로별, 치료별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

  • 조사의 목표와 목적
  • 이 조사를 시행하는 이유
  • 리포트의 범위
  • 정보원
  • 조사 방법
  • 지역적 내역
  • 애널리스트의 경력
  • BCC 커스텀 조사
  • 관련 BCC 조사 리포트

제2장 정리와 하이라이트

제3장 시장과 기술 배경

  • 서론
  • 시장의 진화

제4장 COVID-19 팬데믹의 영향

  • COVID-19의 시장에 대한 영향
  • 건강 관련 상품의 소비 동향 변화

제5장 시장 역학

  • 개요
  • 아나필락시스의 발생률 상승
  • 표적치료의 보급률 증가
  • 시장 억제요인
  • 대체 약물전달 루트의 존재
  • 엄격한 규제 시나리오

제6장 시장 내역, 제품 유형별

  • 자기주사기 시장, 제품 유형별
  • 일회용 자기주사기
  • 시장 규모와 예측
  • 리유저블 자기주사기
  • 시장 규모와 예측

제7장 시장 내역, 투여 경로별

  • 자기주사기 시장, 투여 경로별
  • 근육내
  • 시장 규모와 예측
  • 피하
  • 시장 규모와 예측

제8장 시장의 내역, 치료별

  • 아나필락시스
  • 시장 규모와 예측
  • 류마티스 관절염
  • 시장 규모와 예측
  • 다발성 경화증
  • 시장 규모와 예측
  • 당뇨병
  • 시장 규모와 예측
  • 기타
  • 시장 규모와 예측

제9장 시장의 내역, 최종사용자별

  • 홈케어 설비
  • 시장 규모와 예측
  • 병원·진료소
  • 시장 규모와 예측
  • 외래 치료 시설
  • 시장 규모와 예측

제10장 시장 내역, 지역별

  • 북미
  • 미국
  • 캐나다
  • 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타
  • 아시아태평양
  • 중국
  • 일본
  • 인도
  • 기타
  • 라틴아메리카
  • 중동과 아프리카

제11장 규제 시나리오

  • 의료기기의 정의와 분류
  • 미국의 규제
  • 연방 규칙집
  • 연방 규칙집의 전자 코드
  • 시판전 신고 510(k) 클리어런스
  • 510(k) 면제 디바이스
  • 시판전 승인
  • 유럽의 규제
  • 북미 국가의 규제
  • 미국의 규제
  • 캐나다의 규제
  • 라틴아메리카의 규제
  • 아시아태평양의 규제
  • 향후 규제 동향

제12장 경쟁 구도

  • 개요
  • 기업 순위

제13장 기업 개요

  • ABBVIE INC.
  • AMGEN INC.
  • ANTARES PHARMA INC.
  • BECTON, DICKINSON AND CO.
  • ELI LILLY AND CO.
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK KGAA
  • SHL MEDICAL AG
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • YPSOMED
KSA 21.11.25

List of Tables

  • Summary Table : Global Market for Autoinjectors, by Region, Through 2026
  • Table 1 : Global Market for Autoinjectors, by Product Type, Through 2026
  • Table 2 : Global Market for Disposable Autoinjectors, by Region, Through 2026
  • Table 3 : Global Market for Reusable Autoinjectors, by Region, Through 2026
  • Table 4 : Global Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 5 : Global Market for Intramuscular Autoinjectors, by Region, Through 2026
  • Table 6 : Global Market for Subcutaneous Autoinjectors, by Region, Through 2026
  • Table 7 : Global Market for Autoinjectors, by Therapy, Through 2026
  • Table 8 : Global Market for Autoinjectors for Anaphylaxis Therapy, by Region, Through 2026
  • Table 9 : Global Market for Autoinjectors for Rheumatoid Arthritis Therapy, by Region, Through 2026
  • Table 10 : Global Market for Autoinjectors for Multiple Sclerosis Therapy, by Region, Through 2026
  • Table 11 : Global Market for Autoinjectors for Diabetes Therapy, by Region, Through 2026
  • Table 12 : Global Market for Autoinjectors for Other Therapies, by Region, Through 2026
  • Table 13 : Global Market for Autoinjectors, by End User Setting, Through 2026
  • Table 14 : Global Market for Autoinjectors Used in Home Care Settings, by Region, Through 2026
  • Table 15 : Global Market for Autoinjectors Used in Hospitals and Clinics, by Region, Through 2026
  • Table 16 : Global Market for Injectors Used in Ambulatory Care Settings, by Region, Through 2026
  • Table 17 : Global Market for Autoinjectors, by Region, Through 2026
  • Table 18 : North American Market for Autoinjectors, by Product Type, Through 2026
  • Table 19 : North American Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 20 : North American Market for Autoinjectors, by Therapy, Through 2026
  • Table 21 : North American Market for Autoinjectors, by End User Setting, Through 2026
  • Table 22 : North American Market for Autoinjectors, by Country, Through 2026
  • Table 23 : European Market for Autoinjectors, by Product Type, Through 2026
  • Table 24 : European Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 25 : European Market for Autoinjectors, by Therapy, Through 2026
  • Table 26 : European Market for Autoinjectors, by End User Setting, Through 2026
  • Table 27 : European Market for Autoinjectors, by Country, Through 2026
  • Table 28 : Asia-Pacific Market for Autoinjectors, by Product Type, Through 2026
  • Table 29 : Asia-Pacific Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 30 : Asia-Pacific Market for Autoinjectors, by Therapy, Through 2026
  • Table 31 : Asia-Pacific Market for Autoinjectors, by End User Setting, Through 2026
  • Table 32 : Asia-Pacific Market for Autoinjectors, by Country, Through 2026
  • Table 33 : Latin American Market for Autoinjectors, by Product Type, Through 2026
  • Table 34 : Latin American Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 35 : Latin American Market for Autoinjectors, by Therapy, Through 2026
  • Table 36 : Latin American Market for Autoinjectors, by End User Setting, Through 2026
  • Table 37 : Middle Eastern and African Market for Autoinjectors, by Product Type, Through 2026
  • Table 38 : Middle Eastern and African Market for Autoinjectors, by Route of Administration, Through 2026
  • Table 39 : Middle Eastern and African Market for Autoinjectors, by Therapy, Through 2026
  • Table 40 : Middle Eastern and African Market for Autoinjectors, by End User Setting, Through 2026
  • Table 41 : Class I and Class II Exempt Devices
  • Table 42 : Differences Between U.S. and European Government Regulations for Medical Devices
  • Table 43 : Regulation in Selected Asia-Pacific Countries
  • Table 44 : Top Five Companies in the Autoinjector Market, 2020
  • Table 45 : Recent Developments in the Autoinjector Market, 2018 to 2021
  • Table 46 : AbbVie: Product Portfolio
  • Table 47 : Amgen: Product Portfolio
  • Table 48 : Amgen: Recent Developments, 2021
  • Table 49 : Antares Pharma: Product Portfolio
  • Table 50 : Antares Pharma: Recent Developments
  • Table 51 : BD: Product Portfolio
  • Table 52 : BD: Recent Developments
  • Table 53 : Eli Lilly: Product Portfolio
  • Table 54 : Eli Lilly: Recent Developments
  • Table 55 : GlaxoSmithKline PLC: Products
  • Table 56 : GlaxoSmithKline PLC: Recent Developments
  • Table 57 : Johnson & Johnson: Product Portfolio
  • Table 58 : Johnson & Johnson: Recent Developments
  • Table 59 : Merck KGaA: Product Portfolio
  • Table 60 : SHL Medical AG: Product Portfolio
  • Table 61 : SHL Medical Ag: Recent Developments
  • Table 62 : Teva Pharmaceutical: Product Portfolio
  • Table 63 : Teva Pharmaceutical: Recent Developments
  • Table 64 : Ypsomed: Product Portfolio
  • Table 65 : Ypsomed: Recent Developments

List of Figures

  • Summary Figure A : Global Market for Autoinjectors, by Region, 2019-2026
  • Summary Figure B : Global Market Shares for Autoinjectors, by Region, 2020
  • Figure 1 : Global Market Share for Autoinjectors, by Product Type, 2020
  • Figure 2 : Global Market for Autoinjectors, by Product Type, 2019-2026
  • Figure 3 : Global Market for Disposable Autoinjectors, 2019-2026
  • Figure 4 : Global Market for Reusable Autoinjectors, 2019-2026
  • Figure 5 : Global Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 6 : Global Market for Autoinjectors, by Route of Administration, 2019-2026
  • Figure 7 : Global Market for Intramuscular Autoinjectors, 2019-2026
  • Figure 8 : Global Market for Subcutaneous Autoinjectors, 2019-2026
  • Figure 9 : Global Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 10 : Global Market for Autoinjectors, by Therapy, 2019-2026
  • Figure 11 : Global Market for Autoinjectors for Anaphylaxis Therapy, 2019-2026
  • Figure 12 : Global Market for Autoinjectors for Rheumatoid Arthritis Therapy, 2019-2026
  • Figure 13 : Global Market for Autoinjectors for Multiple Sclerosis Therapy, 2019-2026
  • Figure 14 : Global Market for Autoinjectors for Diabetes Therapy, 2019-2026
  • Figure 15 : Global Market for Autoinjectors for Other Therapies, 2019-2026
  • Figure 16 : Global Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 17 : Global Market for Autoinjectors Used in Home Care Settings, 2019-2026
  • Figure 18 : Global Market for Autoinjectors Used in Home Care Settings, by Region, 2019-2026
  • Figure 19 : Global Market for Autoinjectors Used in Hospitals and Clinics, 2019-2026
  • Figure 20 : Global Market for Autoinjectors Used in Hospitals and Clinics, by Region, 2019-2026
  • Figure 21 : Global Market for Autoinjectors Used in Ambulatory Care Settings, 2019-2026
  • Figure 22 : Global Market for Autoinjectors Used in Ambulatory Care Settings, by Region, 2019-2026
  • Figure 23 : Global Market Shares of Autoinjectors, by Region, 2020
  • Figure 24 : North American Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 25 : North American Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 26 : North American Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 27 : North American Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 28 : North American Market Shares of Autoinjectors, by Country, 2020
  • Figure 29 : U.S. Market for Autoinjectors, 2019-2026
  • Figure 30 : Canadian Market for Autoinjectors, 2019-2026
  • Figure 31 : European Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 32 : European Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 33 : European Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 34 : European Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 35 : European Market Shares of Autoinjectors, by Country, 2020
  • Figure 36 : German Market for Autoinjectors, 2019-2026
  • Figure 37 : U.K. Market for Autoinjectors, 2019-2026
  • Figure 38 : French Market for Autoinjectors, 2019-2026
  • Figure 39 : Italian Market for Autoinjectors, 2019-2026
  • Figure 40 : Spanish Market for Autoinjectors, 2019-2026
  • Figure 41 : Rest of European Market for Autoinjectors, 2019-2026
  • Figure 42 : Asia-Pacific Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 43 : Asia-Pacific Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 44 : Asia-Pacific Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 45 : Asia-Pacific Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 46 : Asia-Pacific Market Shares of Autoinjectors, by Country, 2020
  • Figure 47 : Chinese Market for Autoinjectors, 2019-2026
  • Figure 48 : Japanese Market for Autoinjectors, 2019-2026
  • Figure 49 : India's Market for Autoinjectors, 2019-2026
  • Figure 50 : Rest of Asia-Pacific Market for Autoinjectors, 2019-2026
  • Figure 51 : Latin American Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 52 : Latin American Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 53 : Latin American Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 54 : Latin American Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 55 : Middle Eastern and African Market Shares of Autoinjectors, by Product Type, 2020
  • Figure 56 : Middle Eastern and African Market Shares of Autoinjectors, by Route of Administration, 2020
  • Figure 57 : Middle Eastern and African Market Shares of Autoinjectors, by Therapy, 2020
  • Figure 58 : Middle Eastern and African Market Shares of Autoinjectors, by End User Setting, 2020
  • Figure 59 : Marketing a Medical Device in the U.S.
  • Figure 60 : AbbVie: Annual Revenue, 2016-2020
  • Figure 61 : AbbVie: Revenue Share, by Region, 2020
  • Figure 62 : AbbVie: Revenue Share, by Business Unit, 2020
  • Figure 63 : Amgen: Annual Revenue, 2018-2020
  • Figure 64 : Amgen: Revenue Share, by Region, 2020
  • Figure 65 : Antares Pharma: Annual Revenue, 2018-2020
  • Figure 66 : Antares Pharma: Revenue Share, by Region, 2020
  • Figure 67 : BD: Annual Revenue, 2018-2020
  • Figure 68 : BD: Revenue Share, by Region, 2020
  • Figure 69 : BD: Revenue Share, by Business Segment, 2020
  • Figure 70 : Eli Lilly: Annual Revenue, 2017-2020
  • Figure 71 : Eli Lilly: Revenue Share, by Region, 2020
  • Figure 72 : Eli Lilly: Revenue Share, by Segment, 2020
  • Figure 73 : GlaxoSmithKline PLC: Annual Revenue, 2017-2020
  • Figure 74 : GlaxoSmithKline PLC: Revenue Share, by Business Segment, 2020
  • Figure 75 : GlaxoSmithKline PLC: Revenue Share, by Region, 2020
  • Figure 76 : Johnson & Johnson: Annual Revenue, 2016-2019
  • Figure 77 : Johnson & Johnson: Revenue Share, by Region, 2019
  • Figure 78 : Johnson & Johnson: Revenue Share, by Business Unit, 2019
  • Figure 79 : Merck KGaA: Annual Revenue, 2019-2020
  • Figure 80 : Merck KGaA: Revenue Share, by Region, 2020
  • Figure 81 : Merck KGaA: Revenue Share, by Business Segment, 2020
  • Figure 82 : Teva Pharmaceutical: Annual Revenue, 2017-2020
  • Figure 83 : Ypsomed: Annual Revenue, 2018-2020

Highlights:

The global market for autoinjectors should grow from $41.5 billion in 2021 to $85.2 billion by 2026, at compound annual growth rate (CAGR) of 15.5% for the period of 2021-2026.

The North American market for autoinjectors should grow from $15.1 billion in 2021 to $28.4 billion by 2026, at a CAGR of 13.4% for the period of 2021-2026.

Asia-Pacific market for autoinjectors should grow from $10.2 billion in 2021 to $22.6 billion by 2026, at a CAGR of 17.2% for the period of 2021-2026.

Report Scope:

This report examines the current market and projected market potential for autoinjectors. It offers a detailed analysis of the competitive environment, market background, technology, drivers and restraints, and market growth trends. The report also includes market projections to 2026 and rankings for key market players. The report segments the market for autoinjectors based on the type of product, route of administration, therapy, end user and geography or region.

The market by type of product is further segmented into disposable and reusable autoinjectors. The market by route of administration is further segmented into intramuscular and subcutaneous. The market by therapy is further segmented into anaphylaxis, rheumatoid arthritis, multiple sclerosis, diabetes, and others. The market by end user is further segmented into home care settings, hospitals and clinics, and ambulatory care settings.

The market by region is segmented into North America, Europe, the Asia-Pacific region, and the Rest of the World. Analyses of major countries are covered in the report. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Estimated values used are based on autoinjector manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

  • 41 data tables and 25 additional tables
  • Detailed review of the global market for autoinjectors within the medical devices industry
  • Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Evaluation and forecast the overall autoinjectors market size in dollar value term, and corresponding market share analysis by product type, route of administration, therapy, end user, and region
  • Discussion of key market dynamics (DROs), technology advancements, regulatory scenario, pricing analysis, and competitive environment of the vendor companies
  • Country specific data and market value analysis for the U.S., Canada, U.K., France, Germany, Italy, Spain, Japan, China and India
  • Insight into the recent industry strategies, key M&A deals, company competitive landscape and value share analysis of the key players operating in global autoinjectors market
  • Highlights of the market potential for autoinjectors, opportunities and gaps estimating current and future demand, and impact of COVID-19 on the progress of this market
  • Discussion of competitive intensity among the leading market participants, their global rankings and recent developments in the autoinjector market
  • Company profile descriptions of the leading manufacturers and suppliers of autoinjector devices including AbbVie Inc., Amgen Inc., Becton, Dickinson and Co., Eli Lilly, GlaxoSmithKline PLC, Johnson & Johnson, Merck KGaA, and Teva Pharmaceutical

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Introduction
  • Market Evolution

Chapter 4 Impact of COVID-19 Pandemic

  • Impact of COVID-19 on Markets
  • Changes in Consumption Trends for Health-Related Products

Chapter 5 Market Dynamics

  • Overview
  • Rising Incidence of Anaphylaxis
  • Growing Prevalence of Targeted Therapies
  • Market Restraints
  • Presence of Alternate Drug Delivery Routes
  • Stringent Regulatory Scenario

Chapter 6 Market Breakdown by Product Type

  • Market for Autoinjectors by Product Type
  • Disposable Autoinjectors
  • Market Size and Forecast
  • Reusable Autoinjectors
  • Market Size and Forecast

Chapter 7 Market Breakdown by Route of Administration

  • Market for Autoinjectors by Route of Administration
  • Intramuscular
  • Market Size and Forecast
  • Subcutaneous
  • Market Size and Forecast

Chapter 8 Market Breakdown by Therapy

  • Anaphylaxis
  • Market Size and Forecast
  • Rheumatoid Arthritis
  • Market Size and Forecast
  • Multiple Sclerosis
  • Market Size and Forecast
  • Diabetes
  • Market Size and Forecast
  • Others
  • Market Size and Forecast

Chapter 9 Market Breakdown by End User

  • Home Care Settings
  • Market Size and Forecast
  • Hospitals and Clinics
  • Market Size and Forecast
  • Ambulatory Care Settings
  • Market Size and Forecast

Chapter 10 Market Breakdown by Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa

Chapter 11 Regulatory Scenarios

  • Medical Device Definition and Classification
  • Regulations in the U.S.
  • Code of Federal Regulations
  • Electronic Code of Federal Regulations
  • Premarket Notification 510(k) Clearance to Market
  • 510(k) Exempt Devices
  • Pre-Market Approval
  • European Regulations
  • Regulation in North American Countries
  • U.S. Regulations
  • Canadian Regulations
  • Regulation in Latin America
  • Regulation in Asia-Pacific
  • Future Regulatory Trends

Chapter 12 Competitive Landscape

  • Overview
  • Company Rankings

Chapter 13 Company Profiles

  • ABBVIE INC.
  • AMGEN INC.
  • ANTARES PHARMA INC.
  • BECTON, DICKINSON AND CO.
  • ELI LILLY AND CO.
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK KGAA
  • SHL MEDICAL AG
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • YPSOMED
Back to Top
전화 문의
F A Q